As Acuity Brands (AYI) Market Value Declined, Shareholder Jacobson & Schmitt Advisors Has Upped Its Stake; Platinum Investment Management LTD Increased Holding in Infinity Pharmaceuticals (INFI) by $601,600 as Share Value Declined

February 19, 2018 - By Marie Mckinney

Kerr Neilson increased its stake in Infinity Pharmaceuticals Inc (INFI) by 74.25% based on its latest 2017Q3 regulatory filing with the SEC. Platinum Investment Management Ltd bought 601,600 shares as the company’s stock declined 27.05% while stock markets rallied. The hedge fund run by Kerr Neilson held 1.41 million shares of the health care company at the end of 2017Q3, valued at $1.88 million, up from 810,232 at the end of the previous reported quarter. Platinum Investment Management Ltd who had been investing in Infinity Pharmaceuticals Inc for a number of months, seems to be bullish on the $94.32M market cap company. It closed at $1.86 lastly. It is down 60.96% since February 19, 2017 and is downtrending. It has underperformed by 77.66% the S&P500.

Jacobson & Schmitt Advisors Llc increased its stake in Acuity Brands Inc (AYI) by 31.17% based on its latest 2017Q3 regulatory filing with the SEC. Jacobson & Schmitt Advisors Llc bought 3,948 shares as the company’s stock declined 23.17% while stock markets rallied. The institutional investor held 16,615 shares of the building products company at the end of 2017Q3, valued at $2.85M, up from 12,667 at the end of the previous reported quarter. Jacobson & Schmitt Advisors Llc who had been investing in Acuity Brands Inc for a number of months, seems to be bullish on the $6.31B market cap company. The stock decreased 1.53% or $2.35 during the last trading session, reaching $151.14. About 336,452 shares traded. Acuity Brands, Inc. (NYSE:AYI) has declined 31.18% since February 19, 2017 and is downtrending. It has underperformed by 47.88% the S&P500.

Investors sentiment decreased to 0.84 in 2017 Q3. Its down 0.01, from 0.85 in 2017Q2. It is negative, as 40 investors sold AYI shares while 132 reduced holdings. 38 funds opened positions while 106 raised stakes. 41.52 million shares or 6.20% less from 44.26 million shares in 2017Q2 were reported. Northern Trust Corporation invested 0.02% in Acuity Brands, Inc. (NYSE:AYI). Ameritas Invest Prns owns 1,049 shares. Mason Street Advsr Lc reported 5,843 shares stake. Verition Fund Management Limited Liability Company holds 2,349 shares. Andra Ap invested in 8,200 shares. Us Bancorp De reported 20,586 shares. Public Employees Retirement Association Of Colorado owns 0.01% invested in Acuity Brands, Inc. (NYSE:AYI) for 7,990 shares. Gemmer Asset Mgmt Limited Com holds 23 shares or 0% of its portfolio. Caxton Associates Limited Partnership invested in 0.03% or 5,000 shares. Teachers Retirement System Of The State Of Kentucky stated it has 0.01% in Acuity Brands, Inc. (NYSE:AYI). Bluecrest Mgmt holds 0.18% in Acuity Brands, Inc. (NYSE:AYI) or 25,592 shares. 4,209 are owned by Bb&T Corp. Apg Asset Management Nv holds 30,023 shares or 0.01% of its portfolio. Savings Bank Of Montreal Can holds 0.01% or 87,433 shares. Greenleaf invested in 209 shares or 0% of the stock.

Among 21 analysts covering Acuity Brands Inc. (NYSE:AYI), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Acuity Brands Inc. had 59 analyst reports since August 21, 2015 according to SRatingsIntel. Williams Capital Group initiated the stock with “Buy” rating in Friday, September 30 report. The stock of Acuity Brands, Inc. (NYSE:AYI) has “Buy” rating given on Thursday, June 29 by Oppenheimer. The firm has “Neutral” rating given on Thursday, August 25 by Roth Capital. As per Thursday, August 25, the company rating was initiated by TH Capital. The firm earned “Outperform” rating on Tuesday, December 1 by Oppenheimer. The rating was maintained by Canaccord Genuity with “Buy” on Monday, November 30. The company was maintained on Tuesday, January 9 by Wells Fargo. Canaccord Genuity upgraded the shares of AYI in report on Thursday, October 6 to “Buy” rating. As per Sunday, June 25, the company rating was maintained by Canaccord Genuity. The rating was initiated by Seaport Global on Friday, November 4 with “Buy”.

Platinum Investment Management Ltd, which manages about $22.00B and $3.96 billion US Long portfolio, decreased its stake in Alphabet Inc by 3,100 shares to 178,702 shares, valued at $174.01 million in 2017Q3, according to the filing. It also reduced its holding in Baidu Inc (NASDAQ:BIDU) by 871,320 shares in the quarter, leaving it with 707,780 shares, and cut its stake in Acceleron Pharma Inc (NASDAQ:XLRN).

Since October 3, 2017, it had 1 insider purchase, and 0 sales for $2.01 million activity.

Investors sentiment decreased to 0.47 in 2017 Q3. Its down 0.16, from 0.63 in 2017Q2. It turned negative, as 15 investors sold INFI shares while 23 reduced holdings. 6 funds opened positions while 12 raised stakes. 27.30 million shares or 18.05% less from 33.31 million shares in 2017Q2 were reported. Goldman Sachs Grp Incorporated has 0% invested in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI). Fincl Bank Of Mellon Corp holds 0% or 45,985 shares in its portfolio. Grp One Trading LP holds 0% in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) or 15,072 shares. Moreover, Tortoise Investment Management Limited Liability Corporation has 0% invested in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI). Federated Invsts Pa has invested 0% in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI). Pinnacle Assoc Limited holds 11,524 shares. Moreover, Wells Fargo And Communication Mn has 0% invested in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) for 13,930 shares. State Street holds 0% of its portfolio in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) for 67,405 shares. Blair William Il reported 12,250 shares. Jpmorgan Chase & invested 0% of its portfolio in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI). Virtu Financial Limited Liability Corporation owns 10,339 shares for 0% of their portfolio. Morgan Stanley stated it has 84,370 shares or 0% of all its holdings. Northern reported 379,443 shares. D E Shaw Communications invested 0% of its portfolio in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI). Royal Fincl Bank Of Canada has invested 0% in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI).

Among 9 analysts covering Infinity Pharmaceutical (NASDAQ:INFI), 2 have Buy rating, 0 Sell and 7 Hold. Therefore 22% are positive. Infinity Pharmaceutical had 16 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, June 14 the stock rating was upgraded by Wedbush to “Neutral”. The stock of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) earned “Outperform” rating by Wells Fargo on Thursday, October 12. The stock of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) has “Market Perform” rating given on Tuesday, June 14 by JMP Securities. The firm has “Market Perform” rating by William Blair given on Wednesday, June 15. Wedbush maintained the shares of INFI in report on Thursday, February 25 with “Neutral” rating. The rating was downgraded by to “Neutral” on Tuesday, June 14. The rating was downgraded by Wedbush to “Underperform” on Tuesday, March 22. The rating was maintained by JMP Securities with “Market Outperform” on Wednesday, March 9. The rating was maintained by RBC Capital Markets on Friday, August 7 with “Outperform”. The stock of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) has “Outperform” rating given on Wednesday, March 2 by FBR Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: